Bristol-Meyers Squibb Acquires Flexus Biosciences for $1,250,000,000

  • Feed Type
  • Date
    2/23/2015
  • Company Name
    Flexus Biosciences
  • Mailing Address
    75 Shoreway Road San Carlos, CA 94070 USA
  • Company Description
    Founded with the mission to create new cancer therapeutics through an innovative application of unexploited insights in immunology.
  • Website
    http://www.flexusbio.com
  • Transaction Type
    M&A
  • Transaction Amount
    $1,250,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The transaction has a potential total consideration of $1.25 billion, including $800 million upfront and development milestones that, upon achievement, could total up to $450 million.

Trending on Xconomy